USD 1.14
Price
-0.10
(-8.06%)
Day Change
|
|
---|
ZVSA, ファンダメンタルスコアはnot good (ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
Deepscope 分析 |
|
41% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 4 |
Magic Formula Rank by ROA |
N/A
|
Magic Formula Rank by ROE |
N/A
|
Magic Formula Rank by ROIC |
N/A
|
Price | 1.14 |
PBV / Sector |
0.04 / 1.56
GREAT
|
Earning Per Share | 491.97 |
PE / Sector |
0.00 / 16.11
|
PEG or PE/Growth / Sector |
N/A / 5.60
|
Average 1M Daily Value |
0.19 M
GREAT
|
Average 1W Daily Value |
0.44 M
GREAT
|
Timing Factors |
|
42% |
Financial Health |
|
41% |
ポイントになる統計 |
|
37% |
配当 |
|
8% |
登録情報 |
Analyze Date | 2024-12-21 07:38:56 |
Symbol | ZVSA |
Name | ZYVERSA THERAPEUTICS INC. |
Sector | Healthcare >> Biotechnology |
Market | NASDAQ |
Listed Shares | 2.34 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 2.91 / 3,466.05 |
ニュース |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |